Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Applying to Saint Alphonsus Regional Medical Center - Boise · Boise, Idaho
Answer a few short questions to share with the research team.